Is CNS Pharmaceuticals Inc (CNSP) a Poor Choice in the Healthcare Sector?

CNS Pharmaceuticals Inc (CNSP) is around the bottom of the Healthcare sector according to InvestorsObserver. CNSP received an overall rating of 46, which means that it scores higher than 46% of stocks. Additionally, CNS Pharmaceuticals Inc scored a 27 in the Healthcare sector, ranking it higher than 27% of stocks in that sector.

CNSP has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CNSP!

See Full CNSP Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With CNS Pharmaceuticals Inc Stock Today?

CNS Pharmaceuticals Inc (CNSP) stock is trading at $2.09 as of 1:17 PM on Tuesday, Nov 21, a drop of -$0.37, or -15.24% from the previous closing price of $2.46. The stock has traded between $1.96 and $2.47 so far today. Volume today is 106,315 compared to average volume of 105,885. Click Here to get the full Stock Report for CNS Pharmaceuticals Inc stock.